Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

被引：0
|
作者：
Oleksandr Ekshyyan
Tara N Moore-Medlin
Matthew C Raley
Kunal Sonavane
Xiaohua Rong
Michael A Brodt
Fleurette Abreo
Jonathan Steven Alexander
Cherie-Ann O Nathan
机构：
[1] Louisiana State University Health Sciences Center,Department of Otolaryngology/Head and Neck Surgery
[2] Feist-Weiller Cancer Center,undefined
[3] LSUHSC,undefined
[4] Department of Pathology,undefined
[5] LSUHSC,undefined
[6] Department of Cellular and Molecular Physiology,undefined
[7] LSUHSC,undefined
来源：
BMC Cancer | / 13卷
关键词：
Head and neck squamous cell carcinoma; Rapamycin; mTOR inhibitors; mTOR; VEGFR-3; VEGFR-2; Lymph node metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
    Ekshyyan, Oleksandr
    Moore-Medlin, Tara N.
    Raley, Matthew C.
    Sonavane, Kunal
    Rong, Xiaohua
    Brodt, Michael A.
    Abreo, Fleurette
    Alexander, Jonathan Steven
    Nathan, Cherie-Ann O.
    BMC CANCER, 2013, 13
  • [2] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Shaun A. Nguyen
    David Walker
    M. Boyd Gillespie
    J. Silvio Gutkind
    Terry A. Day
    Current Treatment Options in Oncology, 2012, 13 : 71 - 81
  • [3] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Nguyen, Shaun A.
    Walker, David
    Gillespie, M. Boyd
    Gutkind, J. Silvio
    Day, Terry A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 71 - 81
  • [4] Recurrent 3p21 deletion in head and neck squamous cell carcinoma identifies SEMA3F as an anti-lymphangiogenic metastasis suppressor gene
    Doci, Colleen L.
    Mikelis, Constantinos M.
    Lionakis, Michail S.
    Molinolo, Alfredo A.
    Gutkind, J. Silvio
    CANCER RESEARCH, 2015, 75
  • [5] Animal models of head and neck squamous cell carcinoma
    Supsavhad, Wachiraphan
    Dirksen, Wessel P.
    Martin, Chelsea K.
    Rosol, Thomas J.
    VETERINARY JOURNAL, 2016, 210 : 7 - 16
  • [6] Preclinical models in head and neck squamous cell carcinoma
    Chaves, Patricia
    Garrido, Maria
    Oliver, Javier
    Perez-Ruiz, Elisabeth
    Barragan, Isabel
    Rueda-Dominguez, Antonio
    BRITISH JOURNAL OF CANCER, 2023, 128 (10) : 1819 - 1827
  • [7] Mouse Models for Head and Neck Squamous Cell Carcinoma
    Zhou, J.
    Liu, C.
    Amornphimoltham, P.
    Cheong, S. C.
    Gutkind, J. S.
    Chen, Q.
    Wang, Z.
    JOURNAL OF DENTAL RESEARCH, 2024, 103 (06) : 585 - 595
  • [8] Preclinical models in head and neck squamous cell carcinoma
    Patricia Chaves
    María Garrido
    Javier Oliver
    Elisabeth Pérez-Ruiz
    Isabel Barragan
    Antonio Rueda-Domínguez
    British Journal of Cancer, 2023, 128 : 1819 - 1827
  • [9] mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma
    Schedel, Fiona
    Pries, Ralph
    Thode, Beate
    Wollmann, Brigitte
    Wulff, Sandra
    Jocham, Dieter
    Wollenberg, Barbara
    Kausch, Ingo
    ONCOLOGY REPORTS, 2011, 25 (03) : 763 - 768
  • [10] EGFR Inhibitors for the Treatment of Squamous Cell Carcinoma of the Head and Neck
    Mehra, Ranee
    Cohen, Roger B.
    Harari, Paul M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (02) : 176 - 184
12345